AAAAAA
Results: 1-25/84
Authors:
MONNET I
BRIENZA S
HUGRET F
VOISIN S
GASTIABURU J
SALTIEL JC
SOULIE P
ARMAND JP
CVITKOVIC E
DECREMOUX H
Citation: I. Monnet et al., PHASE-II STUDY OF OXALIPLATIN IN POOR-PROGNOSIS NONSMALL CELL LUNG-CANCER (NSCLC), European journal of cancer, 34(7), 1998, pp. 1124-1127
Authors:
DUCREUX M
ROUGIER P
FANDI A
CLAVEROFABRI MC
VILLING AL
FASSONE F
FANDI L
ZARBA J
ARMAND JP
Citation: M. Ducreux et al., EFFECTIVE TREATMENT OF ADVANCED BILIARY-TRACT CARCINOMA USING 5-FLUOROURACIL CONTINUOUS-INFUSION WITH CISPLATIN, Annals of oncology, 9(6), 1998, pp. 653-656
Authors:
PIVOT X
RAYMOND E
GEDOUIN D
DEGARDIN W
ARMAND JP
LAGUERRE B
LEFEBVRE JL
RIPOCHE V
KAYITALIRE L
SCHNEIDER M
Citation: X. Pivot et al., PHASE-II TRIAL OF MTA (LY231514) IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Annals of oncology, 9, 1998, pp. 366-366
Authors:
DUCREUX M
FIZAZI K
DANIEL C
RUFFLE P
KABOUCHE A
FANDI A
SMITH M
ARMAND JP
Citation: M. Ducreux et al., UPDATED RESULTS OF A PHASE-I TRIAL OF TOMUDEX((R)) (T) IN COMBINATIONWITH OXALIPLATIN (L-OHP) IN ADVANCED SOLID TUMORS - A PROMISING AND ACTIVE COMBINATION, Annals of oncology, 9, 1998, pp. 602-602
Authors:
FIZAZI K
BONNAY M
FOURCAULT D
RUFFIE P
COUTURAS O
SMITH M
GOMENI R
FANDI A
ARMAND JP
Citation: K. Fizazi et al., PHARMACOKINETIC (PK) OF TOMUDEX((R)) (RALTITREXED) (T) AND OXALIPLATIN (0) COMBINATION - PRELIMINARY-RESULTS OF AN ONGOING PHASE-I STUDY, Annals of oncology, 9, 1998, pp. 612-612
Authors:
BOIGE V
RAYMOND E
FABBRO M
PLAZZA J
VASSAL G
RISSE ML
RODIER JM
ARMAND JP
Citation: V. Boige et al., PHASE-II TRIAL AND PHARMACOKINETIC STUDY OF IRINOTECAN (CPT-11) IN PATIENTS WITH GLIOBLASTOMA, Annals of oncology, 9, 1998, pp. 657-657
Authors:
OBERHOFF C
NERI B
AMADORI D
PETRY KU
GAMUCCI T
REBMANN U
NOWROUSIAN MR
VOIGTMANN R
MONFARDINI S
ARMAND JP
HERRMANN R
NETTERPINON J
TUBIANAMATHIEU N
ZWIERZINA H
Citation: C. Oberhoff et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA AND PREVENTION OF TRANSFUSION REQUIREMENT ASSOCIATED WITH SOLID TUMORS - A RANDOMIZED, CONTROLLED-STUDY, Annals of oncology, 9(3), 1998, pp. 255-260
Authors:
WASSERMAN E
MYARA A
LOKIEC F
RIOFRIO M
IMADALOU K
BLEUZEN P
SANTONI J
TRIVIN F
HERAIT P
MAHJOUBI M
ARMAND JP
MISSET JL
CVITKOVIC E
Citation: E. Wasserman et al., BILIRUBIN (BIL) AND SN-38 - PHARMACOKINETIC PHARMACODYNAMICS CORRELATION/, Annals of oncology, 9, 1998, pp. 220-220
Authors:
RAYMOND E
BOIGE V
GATINEAU M
FRAZER S
LAROCHE C
LABBE S
PAUTIER P
DUCREUX M
ARMAND JP
Citation: E. Raymond et al., PHASE-I AND PHARMACOKINETIC STUDY OF DX-8951F, A NOVEL TOPOISOMERASE-1 INHIBITOR, USING A 30 MINUTE INFUSION EVERY 3 WEEKS, Annals of oncology, 9, 1998, pp. 248-248
Authors:
SEITZ JF
DUCREUX M
YCHOU M
BONNAY M
ROUGIER P
MIGNARD D
ARMAND JP
Citation: Jf. Seitz et al., PHASE I II STUDY OF CPT-II IN COMBINATION WITH LV5FU2 (DE GRAMONT-REGIMEN) EVERY 2 WEEKS FOR THE TREATMENT OF COLORECTAL-CANCER (CRC) AFTER5-FU FAILURE/, Annals of oncology, 9, 1998, pp. 261-261
Authors:
FIZAZI K
BAUDIN E
RUFFIE P
DUCREUX M
SORIA JC
LECHEVALIER T
BONNAY M
COUTURAS O
FANDI A
ARMAND JP
Citation: K. Fizazi et al., AN ONGOING PHASE-I TRIAL OF TOMUDEX(R) (T) IN COMBINATION WITH OXALIPLATIN (L-OHP) IN ADVANCED SOLID TUMORS - A PROMISING AND ACTIVE COMBINATION, Annals of oncology, 9, 1998, pp. 460-460
Authors:
CHAOUCHE M
DELORD JP
RAYMOND E
VAYRE L
DUCREUX M
RUFFLE P
RODIER JM
ARMAND JP
Citation: M. Chaouche et al., GEMCITABINE AND VINORELBINE, A PHASE-I STUDY IN PATIENTS WITH ADVANCED MALIGNANCIES, Annals of oncology, 9, 1998, pp. 631-631
Authors:
RIXE O
GATINEAU M
BATOUCHE M
RAYMOND E
DOMENGE C
JANOT F
SCHWAAB G
LUBOINSKI B
ARMAND JP
Citation: O. Rixe et al., SEQUENTIAL NEOADJUVANT CHEMOTHERAPY (SC) FOR HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC), Annals of oncology, 9, 1998, pp. 672-672
Authors:
DEGARDIN M
OLIVEIRA J
GEOFFROIS L
ROLLAND F
ARMAND JP
BASTIT P
CHAUVERGNE J
FARGEOT P
VANGLABBEKE M
LENTZ MA
TRESCA P
BOUDILLET J
FUMOLEAU P
CAPPELAERE P
Citation: M. Degardin et al., AN EORTC-ECSG PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/, Annals of oncology, 9(10), 1998, pp. 1103-1107
Authors:
DECREVOISIER R
BOURHIS J
DOMENGE C
WIBAULT P
KOSCIELNY S
LUSINCHI A
MAMELLE G
JANOT F
JULIERON M
LERIDANT AM
MARANDAS P
ARMAND JP
SCHWAAB G
LUBOINSKI B
ESCHWEGE F
Citation: R. Decrevoisier et al., FULL-DOSE REIRRADIATION FOR UNRESECTABLE HEAD AND NECK-CARCINOMA - EXPERIENCE AT THE GUSTAVE-ROUSSY-INSTITUTE IN A SERIES OF 169 PATIENTS, Journal of clinical oncology, 16(11), 1998, pp. 3556-3562
Authors:
RIVORY LP
HAAZ MC
CANAL P
LOKIEC F
ARMAND JP
ROBERT J
Citation: Lp. Rivory et al., PHARMACOKINETIC INTERRELATIONSHIPS OF IRINOTECAN (CPT-11) AND ITS 3 MAJOR PLASMA METABOLITES IN PATIENTS ENROLLED IN PHASE-I II TRIALS/, Clinical cancer research, 3(8), 1997, pp. 1261-1266
Authors:
FANDI A
TAAMMA A
AZLI N
BACHOUCHI M
YANES B
ARMAND JP
CVITKOVIC E
Citation: A. Fandi et al., PALLIATIVE TREATMENT WITH LOW-DOSE CONTINUOUS-INFUSION 5-FLUOROURACILIN RECURRENT AND OR METASTATIC UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA TYPE/, Head & neck, 19(1), 1997, pp. 41-47
Authors:
ROUGIER P
YCHOU M
SEITZ JF
BONNAY M
MIGNARD D
COUTEAU C
ARMAND JP
DUCREUX M
Citation: P. Rougier et al., PHASE-I II STUDY OF CPT-11 IN COMBINATION WITH LV2FU5 (DE-GRAMONT-REGIMEN) EVERY 2 WEEKS FOR THE TREATMENT OF COLORECTAL-CANCER (CRC) AFTER5FU FAILURE/, European journal of cancer, 33, 1997, pp. 756-756
Authors:
DEGARDIN M
BASTIT P
ROLLAND F
ARMAND JP
CHEVALLIER B
VANGLABBEKE M
BOUDILLET J
TRESCA P
Citation: M. Degardin et al., PHASE-II STUDY OF VINORELBINE (NVB) IN PATIENTS WITH METASTATIC AND OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)/, European journal of cancer, 33, 1997, pp. 843-843
Authors:
CIULEANU TE
CHAHINE A
TODOR N
MONNET I
AZLI N
VOISIN S
RIGGI M
SALTIEL JC
ARMAND JP
RUFFIE P
DECREMOUX H
CVITKOVIC E
Citation: Te. Ciuleanu et al., NEOADJUVANT CISPLATIN-VINDESINE VINORELBINE BASED COMBINATION CHEMOTHERAPY (CT) FOR STAGE-III NONSMALL CELL LUNG-CANCER (NSCLC)/, European journal of cancer, 33, 1997, pp. 1056-1056
Authors:
TRANDAFIR L
RUFFIE P
BOREL C
MONNET I
SOULIE P
ADAMS D
CVITKOVIC E
ARMAND JP
Citation: L. Trandafir et al., HIGHER DOSES OF ALPHA-INTERFERON DO NOT INCREASE THE ACTIVITY OF THE WEEKLY CISPLATIN-INTERFERON COMBINATION IN ADVANCED MALIGNANT MESOTHELIOMA, European journal of cancer, 33(11), 1997, pp. 1900-1902
Authors:
MERROUCHE Y
EXTRA JM
ABIGERGES D
BUGAT R
CATIMEL G
SUC E
MARTY M
HERAIT P
MAHJOUBI M
ARMAND JP
Citation: Y. Merrouche et al., HIGH DOSE-INTENSITY OF IRINOTECAN ADMINISTERED EVERY 3 WEEKS IN ADVANCED CANCER-PATIENTS - A FEASIBILITY STUDY, Journal of clinical oncology, 15(3), 1997, pp. 1080-1086
Authors:
ARMAND JP
Citation: Jp. Armand, NEW ANTICANCER DRUGS IN EUROPE, Chinese medical journal, 110(4), 1997, pp. 297-308
Authors:
ARMAND JP
DOUSSET V
FRANCONI JM
HUOT P
MIEZE S
LACOSTE D
LETENNEUR L
CAILLE JM
Citation: Jp. Armand et al., PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATH Y STUDIED BY MAGNETIZATION-TRANSFER IMAGING, Journal de radiologie, 78(2), 1997, pp. 131-134
Authors:
DOUSSET V
ARMAND JP
LACOSTE D
MIEZE S
LETENNEUR L
DARTIGUES JF
CAILLE JM
Citation: V. Dousset et al., MAGNETIZATION-TRANSFER STUDY OF HIV ENCEPHALITIS AND PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY, American journal of neuroradiology, 18(5), 1997, pp. 895-901